Femtrace Warner Chilcott - Treatment for Menopausal Vasomotor Symptoms
Femtrace has been approved for the relief of the vasomotor symptoms
of menopause. Approval was not granted for the secondary indication
of vulvar-vaginal atrophy. The comapny expects to launch Femtrace
in the first quarter of 2005.
Posted: August 2004
Femtrace (estradiol acetate) FDA Approval History